Loading...

Inspire Medical Systems

DB:2DR
Snowflake Description

High growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2DR
DB
$1B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). The last earnings update was 10 days ago. More info.


Add to Portfolio Compare Print
2DR Share Price and Events
7 Day Returns
-10.6%
DB:2DR
-9.1%
DE Healthcare Services
-1.4%
DE Market
1 Year Returns
-
DB:2DR
-15.9%
DE Healthcare Services
-8%
DE Market
2DR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Inspire Medical Systems (2DR) -10.6% 10.2% -13% - - -
DE Healthcare Services -9.1% -9% -10% -15.9% 49.9% 132.2%
DE Market -1.4% -1.9% -5.8% -8% 25.5% 47%
1 Year Return vs Industry and Market
  • No trading data on 2DR.
  • No trading data on 2DR.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Inspire Medical Systems undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Inspire Medical Systems to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Inspire Medical Systems.

DB:2DR Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:2DR
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 9.5%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.639 (1 + (1- 21%) (2.47%))
0.652
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.54% + (0.8 * 9.46%)
8.11%

Discounted Cash Flow Calculation for DB:2DR using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Inspire Medical Systems is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:2DR DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (USD, Millions) -21.00 -14.00 -2.00 12.00 13.92
Source Analyst x1 Analyst x1 Analyst x1 Analyst x1 Est @ 16%, capped from 45.42%
Present Value
Discounted (@ 8.11%)
-19.42 -11.98 -1.58 8.79 9.43
Present value of next 5 years cash flows $-14.78
DB:2DR DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= $13.92 × (1 + 0.54%) ÷ (8.11% – 0.54%)
$184.97
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= $184.97 ÷ (1 + 8.11%)5
$125.26
DB:2DR Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= $-14.78 + $125.26
$110.48
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $110.48 / 21.40
$4.44
DB:2DR Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:2DR represents 0.86091x of NYSE:INSP
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.86091x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 5.16 x 0.86091
€4.44
Value per share (EUR) From above. €4.44
Current discount Discount to share price of €40.48
= -1 x (€40.48 - €4.44) / €4.44
-810.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Inspire Medical Systems is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Inspire Medical Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Inspire Medical Systems's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:2DR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-09-30) in USD $-2.26
NYSE:INSP Share Price ** NYSE (2018-11-16) in USD $47.02
Europe Healthcare Services Industry PE Ratio Median Figure of 16 Publicly-Listed Healthcare Services Companies 29.21x
Germany Market PE Ratio Median Figure of 415 Publicly-Listed Companies 17.87x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Inspire Medical Systems.

DB:2DR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:INSP Share Price ÷ EPS (both in USD)

= 47.02 ÷ -2.26

-20.77x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Inspire Medical Systems is loss making, we can't compare its value to the Europe Healthcare Services industry average.
  • Inspire Medical Systems is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Inspire Medical Systems's expected growth come at a high price?
Raw Data
DB:2DR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -20.77x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
40.5%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 11 Publicly-Listed Healthcare Services Companies 1.76x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.35x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Inspire Medical Systems, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Inspire Medical Systems's assets?
Raw Data
DB:2DR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-09-30) in USD $4.60
NYSE:INSP Share Price * NYSE (2018-11-16) in USD $47.02
Germany Healthcare Services Industry PB Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 2.68x
Germany Market PB Ratio Median Figure of 553 Publicly-Listed Companies 1.88x
DB:2DR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:INSP Share Price ÷ Book Value per Share (both in USD)

= 47.02 ÷ 4.60

10.23x

* Primary Listing of Inspire Medical Systems.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Inspire Medical Systems is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess Inspire Medical Systems's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Inspire Medical Systems has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Inspire Medical Systems expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
40.5%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Inspire Medical Systems expected to grow at an attractive rate?
  • Inspire Medical Systems's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Inspire Medical Systems's earnings growth is expected to exceed the Germany market average.
  • Inspire Medical Systems's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:2DR Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:2DR Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 40.5%
DB:2DR Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 27.7%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 18.3%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.3%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:2DR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:2DR Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 141 1 6 3
2021-12-31 113 -12 -6 3
2020-12-31 87 -22 -20 5
2019-12-31 63 -28 -28 6
2018-12-31 48 -24 -25 6
DB:2DR Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-09-30 44 -19 -21
2018-06-30 38 -19 -21
2018-03-31 33 -17 -20
2017-12-31 29 -16 -18
2016-12-31 16 -18 -19
2015-12-31 8 -22 -21

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Inspire Medical Systems's earnings are expected to grow significantly at over 20% yearly.
  • Inspire Medical Systems's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:2DR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Inspire Medical Systems Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2DR Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 0.27 0.35 0.19 2.00
2021-12-31 -0.28 -0.16 -0.39 2.00
2020-12-31 -0.88 -0.68 -1.03 3.00
2019-12-31 -1.28 -0.98 -1.48 4.00
2018-12-31 -1.67 -1.57 -1.76 2.00
DB:2DR Past Financials Data
Date (Data in USD Millions) EPS *
2018-09-30 -2.26
2018-06-30 -4.77
2018-03-31 -16.13
2017-12-31 -14.88
2016-12-31 -16.90
2015-12-31 -20.76

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Inspire Medical Systems will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Inspire Medical Systems's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Inspire Medical Systems has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Inspire Medical Systems performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Inspire Medical Systems's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Inspire Medical Systems does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Inspire Medical Systems's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Inspire Medical Systems's 1-year growth to the Europe Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Inspire Medical Systems's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Inspire Medical Systems Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2DR Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-09-30 43.99 -21.30 47.66 6.92
2018-06-30 38.21 -20.63 42.37 6.32
2018-03-31 33.31 -19.53 36.94 6.33
2017-12-31 28.57 -17.51 32.36 6.19
2016-12-31 16.43 -18.53 22.68 7.09
2015-12-31 8.01 -21.34 17.92 7.08

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Inspire Medical Systems has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Inspire Medical Systems has efficiently used its assets last year compared to the Europe Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Inspire Medical Systems improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Inspire Medical Systems's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Inspire Medical Systems has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Inspire Medical Systems's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Inspire Medical Systems's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Inspire Medical Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Inspire Medical Systems's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Inspire Medical Systems's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 5.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Inspire Medical Systems Company Filings, last reported 1 month ago.

DB:2DR Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-09-30 98.31 24.81 120.43
2018-06-30 102.58 24.70 123.96
2018-03-31 -3.96 24.57 17.90
2017-12-31 1.48 16.46 16.14
2016-12-31 -6.56 15.69 6.69
2015-12-31
  • Inspire Medical Systems's level of debt (25.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Inspire Medical Systems's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Information is not available.
  • Unable to confirm if Inspire Medical Systems has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess Inspire Medical Systems's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Inspire Medical Systems has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Inspire Medical Systems's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Inspire Medical Systems dividends. Estimated to be 0% next year.
If you bought €2,000 of Inspire Medical Systems shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Inspire Medical Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Inspire Medical Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:2DR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.5%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:2DR Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31 0.00 1.00
2019-12-31 0.00 2.00
2018-12-31 0.00 2.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Inspire Medical Systems has not reported any payouts.
  • Unable to verify if Inspire Medical Systems's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Inspire Medical Systems's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Inspire Medical Systems has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Inspire Medical Systems's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Inspire Medical Systems's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Inspire Medical Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Inspire Medical Systems has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Inspire Medical Systems's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Timothy Herbert
COMPENSATION $599,561
AGE 55
TENURE AS CEO 11 years
CEO Bio

Mr. Timothy Herbert has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007. Mr. Herbert has over 25 years of experience in new business development including over 10 years at Medtronic and 7 years at Inspire Medical Systems. He has held management positions in product development, clinical research, regulatory, sales, marketing, and healthcare reimbursement. He has been part of the Inspire business since 1996, assuming management of the venture in 1998. With extensive experience in venture development, as well as his detailed knowledge of the Inspire system, OSA disease state, and the sleep diagnostic and therapeutic market, he is well positioned to lead the Inspire organization. Mr. Herbert has a B.S. in Electrical Engineering from North Dakota State University and an M.B.A. from the University of St. Thomas.

CEO Compensation
  • Insufficient data for Timothy to compare compensation growth.
  • Timothy's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Inspire Medical Systems management team in years:

7.2
Average Tenure
52.5
Average Age
  • The average tenure for the Inspire Medical Systems management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Timothy Herbert

TITLE
CEO, President & Director
COMPENSATION
$600K
AGE
55
TENURE
11 yrs

Rick Buchholz

TITLE
Chief Financial Officer
COMPENSATION
$330K
AGE
50
TENURE
4.5 yrs

Randy Ban

TITLE
Senior Vice President of Sales & Marketing
COMPENSATION
$513K
AGE
53
TENURE
9.8 yrs

Steven Jandrich

TITLE
Chief Compliance Officer & VP of Human Resources
AGE
52
TENURE
1.2 yrs

Howard Green

TITLE
Vice President of Marketing

Quan Ni

TITLE
Vice President of Research
Board of Directors Tenure

Average tenure and age of the Inspire Medical Systems board of directors in years:

9.5
Average Tenure
58
Average Age
  • The tenure for the Inspire Medical Systems board of directors is about average.
Board of Directors

Marilyn Nelson

TITLE
Chair of the Board
COMPENSATION
$9K
AGE
78
TENURE
2 yrs

Timothy Herbert

TITLE
CEO, President & Director
COMPENSATION
$600K
AGE
55
TENURE
11 yrs

Joyce Erony

TITLE
Director
AGE
58
TENURE
2 yrs

Shawn McCormick

TITLE
Director
COMPENSATION
$9K
AGE
54
TENURE
1.8 yrs

Casey Tansey

TITLE
Director
AGE
60
TENURE
10.8 yrs

Chau Khuong

TITLE
Director
AGE
42
TENURE
4.6 yrs

Dana Mead

TITLE
Director
AGE
59
TENURE
10.3 yrs

Mudit Jain

TITLE
Director
AGE
49
TENURE
9.5 yrs

Jerry Griffin

TITLE
Director
COMPENSATION
$4K
AGE
73
TENURE
10.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
10. May 18 Buy Amzak Health Investors, Llc Company 07. May 18 07. May 18 125,000 €13.42 €1,677,600
10. May 18 Buy GDN Holdings, LLC Company 07. May 18 07. May 18 62,500 €13.42 €838,800
10. May 18 Buy OrbiMed Advisors, L.L.C. Company 07. May 18 07. May 18 312,500 €13.42 €4,194,000
10. May 18 Buy U.S. Venture Partners Company 07. May 18 07. May 18 187,500 €13.42 €2,516,400
10. May 18 Buy Shawn McCormick Individual 07. May 18 07. May 18 3,000 €13.42 €40,262
10. May 18 Buy Dana Mead Individual 07. May 18 07. May 18 20,000 €13.42 €268,416
10. May 18 Buy Timothy Herbert Individual 07. May 18 07. May 18 350 €13.42 €4,697
10. May 18 Buy Steven Jandrich Individual 07. May 18 07. May 18 2,050 €13.42 €27,513
10. May 18 Buy Richard Buchholz Individual 07. May 18 07. May 18 4,750 €13.42 €63,749
10. May 18 Buy Randy Ban Individual 07. May 18 07. May 18 900 €13.42 €12,079
X
Management checks
We assess Inspire Medical Systems's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Inspire Medical Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

External News
Loading...
Simply Wall St News

Company Info

Map
Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.

Details
Name: Inspire Medical Systems, Inc.
2DR
Exchange: DB
Founded: 2007
$882,376,465
21,400,367
Website: http://www.inspiresleep.com
Address: Inspire Medical Systems, Inc.
9700 63rd Avenue North,
Suite 200,
Maple Grove,
Minnesota, 55369,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE INSP Common Stock New York Stock Exchange US USD 03. May 2018
DB 2DR Common Stock Deutsche Boerse AG DE EUR 03. May 2018
Number of employees
Current staff
Staff numbers
150
Inspire Medical Systems employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2018/11/16 21:02
End of day share price update: 2018/11/16 00:00
Last estimates confirmation: 2018/11/07
Last earnings filing: 2018/11/06
Last earnings reported: 2018/09/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.